Recent Quotes (30 days)

You have no recent quotes
chg | %

Market summary

3:44PM EDT

World markets

Shanghai 4,293.62 +76.55 (1.82%)
Nikkei 225 19,909.09 +274.60 (1.40%)
Hang Seng Index 27,850.49
TSEC 9,533.98
FTSE 100 7,062.93 +10.80 (0.15%)
EURO STOXX 50 3,719.38 +1.34 (0.04%)
CAC 40 5,192.64 +5.05 (0.10%)
S&P TSX 15,325.02 -87.58 (-0.57%)
S&P/ASX 200 5,872.30 +39.20 (0.67%)
BSE Sensex 27,676.04 -210.17 (-0.75%)
TA25 1,683.35 +3.89 (0.23%)
SMI 9,299.43 +55.72 (0.60%)
ATX 2,632.26 +23.96 (0.92%)
IBOVESPA 53,761.27 -193.52 (-0.36%)
SET 1,569.35 +9.03 (0.58%)
BIST100 84,277.65 +1,975.09 (2.40%)
IBEX 11,422.30 +37.70 (0.33%)
WIG 56,226.22 +34.92 (0.06%)
TASI 9,558.88
MERVAL 10,617.29 -206.14 (-1.90%)

Currencies

EUR/USD 1.0738 -0.0013 (-0.12%)
USD/JPY 119.6650 +0.4535 (0.38%)
GBP/USD 1.4928 +0.0017 (0.12%)
USD/CAD 1.2282 +0.0055 (0.45%)
USD/HKD 7.7502 +0.0002 (0.00%)
USD/CNY 6.1993 +0.0026 (0.04%)
AUD/USD 0.7706 -0.0013 (-0.17%)

Bonds

3 Month 0.01% 0.00 (0.00%)
6 Month 0.07% 0.00 (0.00%)
2 Year 0.50% -0.01 (-1.96%)
5 Year 1.33% +0.02 (1.53%)
10 Year 1.91% +0.03 (1.60%)
30 Year 2.58% +0.03 (1.18%)
UPDATE 5-Generic drugmaker Teva makes $40 billion offer for rival Mylan
(Adds source saying Perrigo set to reject Mylan offer, updates share prices). By Tova Cohen and Caroline Humer. TEL AVIV/NEW YORK, April 21 (Reuters) - Teva Pharmaceutical Industries Ltd on Tuesday made an unsolicited $40 billion offer for smaller rival ...
Teva's $40 Billion Bid for Mylan a Winner  
Mylan Is Too Big a Pill for Teva  
Market Chart
17,948.85 -86.08 (-0.48%)
2,097.49 -2.91 (-0.14%)
5,015.17 +20.57 (0.41%)

Top stories

'The experience guests had on Target.com early Sunday morning wasn't acceptable. It's as simple as that.' Target TGT 1.14% was the victim of its own success.
A futures trader was arrested in Great Britain Tuesday for his alleged involvement in the "Flash Crash" of 2010 in which the Dow Jones Industrial Average plunged 600 points in five minutes.
Gannett Co. said its first-quarter earnings soared as growth in the media company's broadcast and digital businesses offset declines at its publishing division.
(Reuters) - U.S. stocks were mixed on Tuesday, with the Dow industrials pulled down by a handful of uninspiring earnings reports, while the Nasdaq was pushed higher by a proposed biotech merger.
Profits are slipping as changing tastes take the sparkle out of the company's core brand. But can a new cost-cutting strategy succeed?

Trends

Popular searches on GoogleChange Mkt Cap
FRO Frontline Ltd. 2.24% 2.51B

Sector summary

Sector Change % down / up
Energy -0.60%
Basic Materials -0.78%
Industrials +0.02%
Cyclical Cons. Goods ... +0.24%
Non-Cyclical Cons. Goods... +0.11%
Financials -0.05%
Healthcare +0.96%
Technology +0.17%
Telecommunications Servi... +0.96%
Utilities -0.66%